Related Experiment Videos
Allogeneic bone marrow transplantation for infantile globoid-cell leukodystrophy (Krabbe's disease)
Maurizio Caniglia1, Ippolita Rana, Rita Maria Pinto
1Bone Marrow Transplant Unit, Hematology Division, Bambino Gesù Children's Hospital IRCCS, Piazza Sant'Onofrio, 400165 Rome, Italy. caniglia@opbg.net
Insights
Early diagnosis is crucial for Krabbe's disease. Bone marrow transplantation (BMT) did not reverse neurological decline in a 4-month-old, highlighting the need for earlier intervention in Krabbe's disease.
Area of Science:
- Neurology
- Genetics
- Pediatrics
Background:
- Krabbe's disease is a rare, fatal genetic disorder affecting the nervous system.
- Early-onset Krabbe's disease presents significant challenges for treatment and prognosis.
- Allogeneic bone marrow transplantation (BMT) is a potential therapeutic option.
Observation:
- A 4-month-old infant with early-onset Krabbe's disease and minimal central nervous system (CNS) involvement underwent BMT from her HLA-identical mother.
- Post-BMT, the child experienced severe hypotonia, hydrocephalus, and neurological deterioration, succumbing 180 days later.
- Successful engraftment and donor-derived enzyme activity (GALC) were confirmed post-transplantation.
Findings:
- Despite successful BMT and chimerism, the patient's neurological deterioration was not reversed.
- The study confirms that delayed diagnosis in early-onset Krabbe's disease limits the efficacy of BMT.
Implications:
- This case underscores the critical importance of timely diagnosis and intervention for Krabbe's disease.
- Further research is needed to determine if extremely early hematopoietic stem cell transplantation in the first weeks of life could be effective.
- Investigating the optimal timing for BMT in Krabbe's disease is essential for improving patient outcomes.
Abstract:
A 4-month-old-girl affected by early expression of Krabbe's disease was treated with allogeneic bone marrow transplantation (BMT). The stem cell donor was her heterozygous HLA-identical mother. The central nervous system (CNS) involvement at diagnosis was evident, but minimal. After BMT the child presented a severe hypotonia and an acute tetraventricular hydrocephalus; she died 180 days after the BMT with progressive severe neurologic deterioration. Leukocyte galactocerebrosidase (GALC) activity was present at donor levels 20 days after BMT. Full donor chimerism was evident 18 days after BMT. This report confirms that in early onset "Krabbe's syndrome" if the diagnosis is delayed after the birth, the progression of the neurologic deterioration is not reversed by BMT. It is to be demonstrated if a very early hemopoietic stem cell transplantation during the first weeks of life, could be appropriate and efficacious.